Apis Capital Advisors’s Amedisys AMED Stock Holding History

Apis Capital Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-7,000	Closed	-$205K	–	44
2014 Q4	$205K	Buy	+7,000	New	+$173K	0.23%	32

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Apis Capital Advisors's AMED Position: Q1 2015 in Review

Apis Capital Advisors sold out of Amedisys (AMED) in Q1 2015, closing a stake of 7,000 shares — an estimated $205K sold.

Apis Capital Advisors first reported a position in AMED in Q4 2014 and held it in 1 quarter. The position peaked at $205K in Q4 2014. 133 funds tracked by Wall St. Rank hold AMED as of Q1 2015.

Apis Capital Advisors reported no remaining Amedisys position as of Q1 2015 after selling out during the quarter.
Apis Capital Advisors sold 7,000 Amedisys shares in Q1 2015, an estimated $205K.
Apis Capital Advisors first reported a position in Amedisys in Q4 2014 and held it in 1 quarter.
Apis Capital Advisors's Amedisys position peaked at $205K in Q4 2014.
133 funds tracked by Wall St. Rank held Amedisys as of Q1 2015.

Based on Apis Capital Advisors's 13F filing for Q1 2015, filed 14 May 2015.